347850 — DND Pharmatech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	1,364	611	18,677	11,437
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	69,107	77,041	188,985	27,582	45,653
Operating Profit	-69,107	-75,677	-188,375	-8,904	-34,216
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-66,995	-72,047	-163,513	4,494	-30,357
Provision for Income Taxes
Net Income After Taxes	-64,284	-69,862	-137,025	3,427	-29,483
Minority Interest
Net Income Before Extraordinary Items
Net Income	-63,406	-68,224	-136,067	3,934	-28,623
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-63,406	-68,224	-136,067	-10,353	-28,623
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-6,080	-6,542	-6,926	-1,273	-2,226
Dividends per Share